Further elaboration regarding the identified cycle effect (and random cycle-to-cycle variability), the quantified direct and delayed effects of [177Lu]Lu-PSMA-I&T tumor exposure on PSA dynamics and the simulated response results for both dosing regimens are provided below. This evidence concerns the gene FOLH1 and neoplasm.